<DOC>
	<DOCNO>NCT01181674</DOCNO>
	<brief_summary>The purpose pilot trial determine whether intensive treatment insulin glargine , metformin , acarbose lifestyle normalize blood glucose level patient recently diagnose type 2 diabetes mellitus compare standard diabetes care .</brief_summary>
	<brief_title>Remission Evaluation Metabolic Interventions Type 2 Diabetes ( REMIT Pilot Trial )</brief_title>
	<detailed_description>This pilot trial 125 patient allocate either usual care ( 1/3 ) , 2 month 4 month intensive lifestyle pharmacotherapy follow cessation drug therapy .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>1. men woman 3080 year age inclusive 2. type 2 diabetes mellitus diagnosed physician within 3 year prior patient enrollment 3. antidiabetic drug regimen ( either drug dose drug ) unchanged 8 week prior screen randomization 4 . HbA1C ≤ 8.5 % oral hypoglycemic agent HbA1C ≤ 7.5 % 1 agent halfmaximal dose 2 agent 5. body mass index ≥ 23 kg/m2 6. negative pregnancy test agreement use reliable method birth control duration trial female childbearing potential 7. ability willingness perform selfmonitoring capillary blood glucose ( SMBG ) 8. ability willingness selfinject insulin 9. provision inform consent . 1. current use insulin therapy 2. history hypoglycemia unawareness , severe hypoglycemia require assistance 3. renal dysfunction evidence serum creatinine ( Cr ) ≥ 124 μmol/l 4. history lactic acidosis diabetic ketoacidosis 5. active liver disease elevate alanine transferase ( ALT ) level ≥ 2.5 time upper limit normal time enrollment 6. history inflammatory bowel disease , colonic ulcer , recent significant bowel surgery , predisposition bowel obstruction 7. cardiovascular disease include : systolic blood pressure &gt; 180 mmHg diastolic blood pressure &gt; 105 mmHg peripheral vascular disease leave bundle branch block third degree AV block tachyarrhythmias bradyarrhythmias uncontrolled ventricular rate stenotic valvular heart disease cardiomyopathy history heart failure history aortic dissection document history angina coronary artery disease history stroke transient ischemic attack 8. pulmonary disease dependence oxygen 9. history disease require intermittent continuous systemic glucocorticoid treatment 10. history major illness life expectancy &lt; 3 year 11. history injury condition significantly limit participant 's ability achieve moderate level physical activity 12. history excessive alcohol intake , acute chronic 13. know hypersensitivity metformin , acarbose , insulin glargine .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Insulin</keyword>
	<keyword>Glargine</keyword>
	<keyword>Metformin</keyword>
	<keyword>Acarbose</keyword>
	<keyword>Diet</keyword>
	<keyword>Exercise</keyword>
	<keyword>Lifestyle</keyword>
</DOC>